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Abstract The mechanism of pyridoxal phosphate (PLP) bind- 
ing to apotryptophanase was investigated using stopped-flow 
kinetics with wild type (WT), W330F and C298S mutants. Based 
on the dependence of the rate constants on PLP concentrations 
for the fast and slow phases detected, two mechanistic schemes 
were proposed. For the WT and C298S mutant, the slow process 
is due to an isomerization of the aldimine complex after its 
formation, and not to the binding to an alternative conformation 
of the apoenzyme, which is the case proposed for the W330F 
mutant. It is suggested that during the cold inactivation process a 
conformational change precedes the aldimine bond cleavage. For 
the W330F apotryptophanase, another conformational change 
occurs subsequent to the aldimine bond cleavage. 
© 1998 Federation of European Biochemical Societies. 
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1. Introduction 
Tryptophanase (tryptophan indole-lyase, EC 4.1.99.1) is a 
widely distributed bacterial pyridoxal phosphate (PLP)-de- 
pendent enzyme that catalyzes c~,l~-elimination a d [3-replace- 
ment reactions of L-tryptophan and of a variety of other [3- 
substituted L-amino acids [1,2]. It consists of four identical 52 
kDa monomers, Each monomer  contains one molecule of 
PLP, which forms an aldimine bond with Lys-270; due to 
this aldimine, Tnase exhibits pH-dependent absorpt ion and 
CD spectra with maxima at 420 and 337 nm [1~].  Tnase 
requires certain monovalent cations (K +, NH~, TI +) for its 
activity and for tight PLP binding [5-7]. The X-ray structure 
of  t ryptophanase from Proteus vulgaris was recently reported 
[81. 
Based on analytical ultracentrifugation apo-Tnase, in the 
presence of either 0.1 M KCI or 0.1 M NaCI and at low 
temperature (5°C) undergoes a concentrat ion-dependent dis- 
sociation into dimers [1]. At  10 mg/ml, however, apo-Tnase 
exists mainly in the tetrameric form [1]. 
Studies of the effect of cooling on tryptophanase have 
shown that WT-Tnase and W330F-Tnase mutant  undergo a 
reversible cold inactivation, yet to a different degree [9]. Re- 
warming of the cold-adapted enzyme leads to restoration of 
80°/,, of the original activity (file = 23 min) and to the reap- 
pearance of the initial spectra (tl/2 = 14 rain) and the tetra- 
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meric structure, The C298S mutant  form exhibited a similar 
cold inactivation, yet a more facile one when compared to 
that observed with the WT form [10]. It was suggested that 
cooling of the enzyme favors its conversion into an inactive 
conformation that releases PLP [9]. We have examined the 
binding of PLP to the apo- form of the WT, W330F and 
C298S mutant  forms of Tnase using single-wavelength 
stopped-flow kinetics to clarify the mechanism of the cold 
induced inactivation. 
2. Materials and methods 
2.1. ChemicaLs' 
S-(o-Nitrophenyl)-L-cysteine (SOPC) was synthesized as described 
in [11]. PLP, Tricine and 2-mercaptoethanol were purchased from 
Sigma. 
2.2. Preparation of enzymes 
WT-Tnase was isolated from cells of Escherichia coli SVS 370 con- 
taining the tnaA gene on plasmids by the procedure described in 
[10,12]. Additional purification was achieved by chromatography on
DEAE-Sephadex A-50 as described in [13]. W330F-Tnase and C298S- 
Tnase were isolated in the same way from cells of E. coli SVS 370 
containing the maA gene with a respective site-directed mutation. 
Apoenzymes were prepared by overnight dialysis of the holoenzyme 
in cold against 0.25 M sodium phosphate buffer containing 0.1 M L- 
alanine, pH 7.0 [3,14]. The protein concentration was determined by 
measurement of absorbance at 278 nm, taking A l% values of 9.19, 
7.64 and 7.95 for holo-WT and W330F-Tnases and apo-WT-Tnase, 
respectively [10,12]. Enzymatic activity was measured by the spectro- 
photometric method using a chromogenic substrate analog, SOPC, as 
described in [15]. The enzyme preparations had a specific activity of 
45 50 Bmol min -~ mg ~ at 25°C and pH 8.0. 
2.3. Stopped-flow studies 
All experiments were performed in 50 mM Tricine-KOH buffer, pH 
7.5, containing 100 mM KCI, 2 mM EDTA and 5 mM 2-mercapto- 
ethanol. The concentrated solution of the apoenzyme (20 mg/ml) was 
incubated at 2°C overnight. At this relatively high concentration no 
dissociation i to dimers occurs [1]. Association rate constants for PLP 
combining with WT or mutant apo-forms were measured under pseu- 
do first order conditions. Shortly prior to measurement (the time 
delay between the dilution and the initiation of data collection was 
less than 1 rain), the apoenzyme solutions (20 mg/ml) were diluted 
with cold (2°C) buffer, and measured at 20 laM (1 mg/ml) while PLP 
was in at least 4-fold excess. No dissociation i to dimers occurs within 
this time period [1,9]. While the PLP solutions were preincubated for 
10 min at 30°C, the apoenzyme solutions at 2°C have been injected 
instantaneously. Equal volumes of these two solutions, 100 B1, were 
injected. Single-wavelength stopped-flow kinetic measurements were 
performed at 30°C, with the temperature controlled by the circulating 
water bath (+ 0.5°C). Stopped-flow kinetic data were obtained with 
an instrument from Kinetic Instruments Inc., using hardware and 
software provided by On-Line Instrument System Inc. (OLIS), as 
described previously [16]. The dead time for this instrument is 1 ms. 
The enzyme solutions were mixed with various concentrations of PLP, 
and the increase in absorbance at 420 nm was followed; the optical 
path was 20 ram. Typically, 512 data points were collected over a 
period of several minutes. Exponential absorbance increases of about 
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0.05 0.1 were observed, with noise levels of _+0.001 A. The rate con- 
stants were evaluated by exponential fitting using the LMF1T pro- 
gram (Levenberg-Marquart lgorithm) provided by OLIS. The valid- 
ity of the fitting was evaluated by inspection of residuals, standard 
deviation or the Durbin-Watson parameters [17]. Typically, rate con- 
stants were estimated to a standard deviation of less than 5%. As 
conducted, this is a non-equilibrium T-jump experiment, followed 
kinetically by the stopped-flow technique. The time delay before the 
T-jump experiment is less than 1 min, which is short relative to the 
time for reactivation of cold-inactivated apotryptophanase (t~/2= 
23 mint. 
3. Results and discussion 
The progress curve of the reaction of the apoenzymes with 
PLP at 420 nm is biphasic and fits well to the sum of two 
exponential relaxations. Attempts to fit the data to a single 
pseudo first order or second order model were unsuccessful. 
For the W330F mutant Tnase, the observed rate constants 
for the fast and slow phases (kol,~) increased in Michaelis- 
Menten manner with increasing [PLP] as shown in Fig. 1. If 
PLP binding occurs with a simple two step mechanism, as- 
suming independent binding [5], as shown in Scheme 1, 
K1 k 1 
E + PLP ~ EPLP ~:~ "-~ EPLP1 
k 2 
Scheme 1. 
then the observed rate constant should increase with increas- 
ing [PLP] according to the following relationship. 
k,,b~ kl X [PLP] 
- F k2 
Kl + [PLPJ 
where kl and k2 represent he forward and reverse rate con- 
stant, and K1 is the dissociation constant of the initial binary 
complex, EPLP. Since the fitting resulted in a Y-intercept 
value that is zero within experimental error, k2 ~ 0, consistent 
with the results of Hogberg-Raibaud [5]. The resultant param- 
eters for the fast phase are k~ = 1.3× 10 - j  s -~ and 
K1=4.5×10 1 mM (Table I). The hyperbolic dependence 
of the observed rate constants tbr the slow phase on [PLP] 
suggests the existence of a second conformation that can bind 
PLP in a mechanism like that shown above. The resultant 
parameters from fitting the data for the slow phase in 
the equation are k ..... =(1 .8+0.2)×10 2 s 1 and K,l,p = 
(1.5_+0.5)× 10 -1 mM. 
These data may be consistent with a mechanism involving 
two different conformations of the enzyme (E and E') both of 
which can bind PLP. The first step is the rapid formation of 
the non-covalent complex (EPLP), which is followed by the 
slow formation of the internal PLP-lysine aldimine bond (E 
K1 
k k6 
E' ~ E'PLP 
PLP 
K2 
Scheme 2. 
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Fig. 1. The observed rate constants for the association of W330F 
apoenzyme with PLP. Two phases were detected. The reactions 
were performed at 30°C in 50 mM Tricine-KOH buffer, pH 7.5, 
containing 100 mM KC1. 
PLP), as shown in Scheme 2. E 'PLP does not directly convert 
to E-PLP in a single step. instead, a conformational change 
precedes the aldimine bond formation. Judging from the rel- 
ative amplitudes of the absorbance changes at high PLP con- 
centration, we estimate that E' represents about 65% of the 
population of cold inactivated W330F Tnase. This could not 
be caused by pre-equilibration of dimers and tetramers prior 
to the T-jump, since the expected percentage of dimers should 
be less than 5%, as was discussed above comparing the exper- 
imental setup time to the t~/2 for dimer-tetramer quilibration. 
The direct interconversion of E and E' must be slower than 
the interconversion of EPLP and E'PLP (ka+k, >>k~+k~;) to 
allow the observation of the two processes. 
In the case of the WT enzyme and the C298S mutant en- 
zymes, the PLP binding reaction also exhibits biphasic kin- 
etics, but in contrast to the results obtained with the W330F 
mutant the rate constant of the slow process is unaffected 
by PLP concentration, as shown in Figs. 2 and 3. The hyper- 
bolic dependence of the first phase on [PLP] implies a non- 
covalent complex similar to that seen for W330F. Thus, the 
average values of the observed rate constant are 
kob = (4.4 _+ 0.9) ×10 :3 s 1 and koj,~=(6.1+0.3)×10 3 s 1 
for the wild type and the C298S mutant, respectively. The 
kinetic parameters for the fast phase are shown in Table 1. 
The similarity in both parameters among the three types of 
enzyme examined, suggests that the fast process is insensitive 
to the mutations. 
K1 
PLP k 1 
E ~ EPLP ~ E -PLP~ " - - - -~  (E'-PLP)I 
k2 
Scheme 3. 
Table l 
Kinetic constants for the reactions of wild type, W330F and C298S 
apoenzymes with PLP 
Tnase kl (s i) Kj (mM) 
WT (I.7-+0.1)× 10 -j (6.5+ 1.0)× 10 J 
W330F (I.3-+0.1)× 10 -~ (4.5 _+0.7)× 10 --~ 
C298S (6.9_+0.7)× 10 -2 (6.4_+ 1.2)× 10 
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The simplest mechanism accounting for the PLP binding to 
the apoform of WT and C298S mutant is given in Scheme 3 
where E is the apoenzyme, EPLP is a non-covalent complex, 
E-PLP is the internal PLP-lysine aldimine and (E-PLPh is an 
isomerized aldimine. Since the slow first order process for WT 
and C298S Tnase is zero order in PLP, it is not coupled 
directly to a PLP binding step. This proposed scheme implies 
that the slow process is due to an isomerization of the aldi- 
mine complex after its formation, and not to the binding to an 
alternate conformation of the apoenzyme, which is the case 
proposed for the W330F mutant. 
Our data do not conform to an anticooperative s quential 
model for binding of PLP to either WT or W330F, which 
would require a non-hyperbolic binding profile for PLP [5]. 
A rate-limiting association of dimers to tetramers, which 
could perhaps be invoked for W330F (for which we do not 
have ultracentrifugation data), would predict a decrease in 
apparent rate constant with [PLP] [18], which is not observed. 
Neither could a model in which preassociation f PLP exclu- 
sively with dimeric apoenzyme, followed by tetramerization f 
the dimeric holoenzyme xplain the biphasic nature of the 
PLP binding process, as shown in Fig. 1. Moreover, as indi- 
cated above, the time course of the experimental procedures i
too short to allow for pre-equilibration f dimers and tet- 
ramers, which leads us to suggest he involvement of two 
different conformations for W330F, i.e. E and E', as the 
most likely explanation for the data. Our kinetic data for 
W330F is compatible with the existence of two different 
PLP binding species without he ability to distinguish between 
two different conformers or two different oligomeric states 
(i.e. dimer and tetramer) or both. However, the latter model 
would require that W330F be predominantly in the dimeric 
form even at 20 mg/ml. 
Based on the microscopic reversibility principle, we now 
provide evidence to our suggestion that during the cold inac- 
tivation process a conformational change precedes the aldi- 
mine bond cleavage [9], as shown for WT and C298S mutant 
Tnases in Scheme 3. C298S, which showed the same activity 
as WT, served as a positive control, as expected for a muta- 
tion at the active site rather than at a tetramer-dimer recog- 
nition surface. Another conformational change, detectable 
only tbr the W330F mutant, occurs subsequent to the aldi- 
mine bond cleavage (Scheme 2). This relatively facile confor- 
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Fig. 2. The observed rate constants for the association of wild type 
apoenzyme with PLP. Two phases were detected, The reactions 
were performed at 30°C in 50 mM Tricine-KOH buffer, pH 7.5, 
containing 100 mM KCI, 
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Fig. 3. The observed rate constants for the association of C298S 
apoenzyme with PLP. Two phases were detected. The reactions 
were performed at 30°C in 50 mM Tricine-KOH buffer, pH 7.5, 
containing 100 mM KCI. 
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mational change would be expected particularly for the 
W330F mutant Tnase, since the replacement of Trp by Phe 
leads to a smaller hydrophobic surface [12], presumably re- 
sulting in an increased flexibility. Such flexibility may account 
for the conformational change ncountered (Scheme 2). How- 
ever, in C298S, the change from Cys to Ser, both of which are 
polar residues, is a more isosteric replacement when compared 
with that in the W330F mutant [10], Accordingly, the muta- 
tion in C298S does not provide the flexibility required for the 
conformational change observed with the W330F mutant. 
Thus, not surprisingly, the C298S mutant enzyme is similar 
to the WT enzyme. Upon cooling the W330F mutant, the 
E'PLP complex in Scheme 2 is favored, shifting the equilib- 
rium away from EPLP and that in turn, results in the break- 
age of the aldimine bond in E-PLP. In both WT and C298S 
mutant ryptophanase, k~l and k{~ in Scheme 2 approach the 
value of zero, leading to negligible concentration f the'E' and 
E'PLP forms. Thus, Scheme 3 describes the stepwise process 
encountered with the latter. 
In conclusion, based on the proposed mechanism for PLP 
binding to the WT and C298S apo-Tnases it is suggested that 
during the cold inactivation process a conformational change 
((E-PLP)~ to E PLP in Scheme 3) precedes the aldimine bond 
cleavage {E-PLP to EPLP, in Scheme 3). Furthermore, based 
on the proposed mechanism for PLP binding to W330F apo- 
tryptophanase, wesuggest that during its relatively more facile 
cold inactivation process, an additional conformational 
change occurs subsequent to the aldimine bond cleavage 
(i.e., EPLP to E'PLP in Scheme 2). Following PLP dissocia- 
tion, the ensuing apo enzyme dissociates into dimers [9]. 
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